(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
Cancer drug discovery has been and continues to be a process of ingenuity, serendip ity, and dogged determination. In an effort to develop and discover better therapies against cancer, investigators all over the world have increased our knowledge of cell biology, biochemistry, and molecular biology. The goal has been to define therapeuti cally exploitable differences between normal and malignant cells. The result has been an increased understanding of cellular and whole-organism biology and an increased respect for the flexibility and resiliency ofbiologically systems. Thus, as some new therapeutic targets have been defined and new therapeutic strategies have been attempted, so have some new biological hurdles resulting from tumor evasion of the intended therapeutic attack been discovered. Historically, anticancer drugs have originated from all available chemical sources. Synthetic molecules from the chemical industry, especially dyestuffs and warfare agents, and natural products from plants, microbes, and fungi have all been potential sources of pharmaceuticals, including anticancer agents. There is no shortage of molecules; the challenge has been and continues to be methods of identifying molecules that have the potential to be therapeutically important in human malignant disease. "Screening" remains the most important and most controversial method in cancer drug discovery. In vitro screens have generally focused on cytotoxicity and have identified several highly cytotoxic molecules. Other endpoints available in vitro are inhibition of proliferation, 3 inhibition of [ H]thymidine incorporation into DNA and various viability assays, based most frequently on dye exclusion or metabolism.
Contents:
Part I. Cytotoxic Agents: Old and New. Nitrogen Mustards, Gerald J. Goldenberg and Malcolm J. Moore. Phosphoramide and Oxazaphosphorine Mustards, Joel E. Wright. Development of the Nitrosoureas, David B. Ludlum. Platinum Complexes, Lloyd R. Kelland. Anthracyclines, Trevor W. Sweatman and Mervyn Israel. Topoisomerase I Inhibitors, Beppino C. Giovanella. DNA Topoisomerase II Inhibitors, Yves Pommier. The Taxoids, Marie-Christine Bissery and Francois Lavelle. Sequence-Selective Groove Binders, Franco Zunino and Giovanni Capranico. Bis-Naphthalimides: Synthesis and Preclinical Evaluation, Cynthia A. Romerdahl and Miguel F. Brana. Part II. Newer Strategies and Targets. The Enediynes, Nina Felice Schor. Matrix Metalloproteinase Inhibitors, William G. Stetler-Stevenson. Interferons and Other Cytokines, Jill A. Hendrzak and Michael J. Brunda. Discovery of TNP-470 and Other Angiogenesis Inhibitors, Donald E. Ingber. Antisense Oligonucleotides, Stanley T. Crooke. Growth Factors and Growth Factor Inhibitors, Edward A. Sausville and Dan L. Longo. Immunoconjugates, Walter A. Blattler, Ravi V. J. Chari, and John M. Lambert. A Case for ras Targeted Agents as Antineoplastics, Judith S. Sebolt-Leopold. Gene Therapy, Peter I. Schrier and Susanne Osanto. Index.
PRODUCT DETAILS
Publisher: Springer (Humana Press Inc.)
Publication date: November, 2010
Pages: 466
Weight: 876g
Availability: Available
Subcategories: Pharmacology
From the same series
Nicola Curtin
Jorge J. Castillo
Moulay A. Alaoui-Jamali
Gail Lewis Phillips
Frank E. Koehn
Beverly A. Teicher
Gary J. Kelloff
Ryan J. Sullivan
Gary K Schwartz
Val R Adams
Antonio Tito Fojo
William D. Figg
Steven Kanner
Giovanni Melillo
Masaki Terabe
Yves Pommier
Derek LeRoith
Beverly A. Teicher
Ann L. Jackman
Jorge J. Castillo
Manuel Hidalgo
Vinata B. Lokeshwar
Beverly A. Teicher
Moulay A. Alaoui-Jamali
Saïd M. Sebti
Frank E. Koehn
Rebecca G. Bagley
Vitaly A. Polunovsky
Benjamin Bonavida
Beverly A. Teicher
Alan M. Gewirtz
Michael A Morse
Janusz W. Rak
J. Silvio Gutkind
Maryann Foote
Zahid H. Siddik
L. Harivardhan Reddy
Gavin J. Gordon
Masaki Terabe
Yves Pommier
Derek LeRoith
Neil J. Clendeninn
Howard L. Kaufman
John D. Haley
Manuel Hidalgo
Beverly A. Teicher
Ulrike Stein
Pat Price
Kelly K. Hunt
Mary L. Disis
David A. Gewirtz
Beverly A. Teicher
Sayed S. Daoud
Nicholas P. Farrell
Vinata B. Lokeshwar
Beverly A. Teicher
Giampietro Gasparini
Doriano Fabbro
Nicholas B. La Thangue
David E. Fisher
John A. Hickman
Godefridus J. Peters
Julian Adams
Sonia Jakowlew
Antonio Giordano
Youcef M. Rustum
Michel Page
Gurmit Singh
Gary J. Kelloff
Moulay A. Alaoui-Jamali
Wafik S. El-Deiry
Keiko Hiyama
Amy M. Fulton
Federico Innocenti
Hak Choy
Sonia Jakowlew
Dennis M. Brown
Michael T. Lotze
Randall E. Harris
Eric Verdin
Benjamin Bonavida
Rebecca G. Bagley
Vitaly A. Polunovsky
Benjamin Bonavida
L. Harivardhan Reddy
V. Craig Jordan
Zahid H. Siddik
Erwin G. van Meir
Amy M. Fulton
Beverly A. Teicher
Keiko Hiyama
Gavin J. Gordon
David S. Ettinger
Federico Innocenti
John D. Haley
Benjamin Bonavida
Antonio Tito Fojo
Sonia Jakowlew
Sonia Jakowlew
Howard L. Kaufman
David A. Gewirtz
Beverly A. Teicher
Sayed S. Daoud
Pat Price
Michael T. Lotze
Ulrike Stein
Kelly K. Hunt
Godefridus J. Peters
Beverly A. Teicher
Eric Verdin